U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 70

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr19:11488825
GRCh38:
Chr19:11378149
EPORY454*Primary familial polycythemia due to EPO receptor mutationUncertain significancecriteria provided, single submitter
2.
GRCh37:
Chr12:111856431
GRCh38:
Chr12:111418627
SH2B3A161VPrimary familial polycythemia due to EPO receptor mutationUncertain significancecriteria provided, single submitter
3.
GRCh37:
Chr12:111855950
GRCh38:
Chr12:111418146
SH2B3M1VPrimary familial polycythemia due to EPO receptor mutationPathogenic
(May 4, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr12:111884608
GRCh38:
Chr12:111446804
SH2B3W262R, W60Rnot provided, Thrombocythemia 1, Primary familial polycythemia due to EPO receptor mutation,
Primary myelofibrosis
Benign
(May 16, 2022)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr9:5070058
GRCh38:
Chr9:5070058
INSL6, JAK2Budd-Chiari syndrome, Thrombocythemia 3, Primary myelofibrosis,
Acute myeloid leukemia, Primary familial polycythemia due to EPO receptor mutation, Acquired polycythemia vera,
not provided, Acquired polycythemia vera
Conflicting interpretations of pathogenicity
(Oct 24, 2022)
criteria provided, conflicting interpretations
6.
GRCh37:
Chr19:11493766
GRCh38:
Chr19:11383090
EPORPrimary familial polycythemia due to EPO receptor mutationBenign
(Jan 12, 2018)
criteria provided, single submitter
7.
GRCh37:
Chr19:11492698
GRCh38:
Chr19:11382022
EPOR, LOC130063571A112VPrimary familial polycythemia due to EPO receptor mutationUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
8.
GRCh37:
Chr19:11492645
GRCh38:
Chr19:11381969
EPOR, LOC130063570A130TPrimary familial polycythemia due to EPO receptor mutationUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
9.
GRCh37:
Chr19:11492395
GRCh38:
Chr19:11381719
EPORPrimary familial polycythemia due to EPO receptor mutationUncertain significance
(Jan 15, 2018)
criteria provided, single submitter
10.
GRCh37:
Chr19:11488628
GRCh38:
Chr19:11377952
EPORPrimary familial polycythemia due to EPO receptor mutationBenign
(Jan 13, 2018)
criteria provided, single submitter
11.
GRCh37:
Chr19:11492394
GRCh38:
Chr19:11381718
EPORG187CPrimary familial polycythemia due to EPO receptor mutationUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
12.
GRCh37:
Chr19:11491861
GRCh38:
Chr19:11381185
EPORE204QPrimary familial polycythemia due to EPO receptor mutation, Inborn genetic diseasesUncertain significance
(Mar 16, 2022)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr19:11491808
GRCh38:
Chr19:11381132
EPORPrimary familial polycythemia due to EPO receptor mutationUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
14.
GRCh37:
Chr19:11489421
GRCh38:
Chr19:11378745
EPORPrimary familial polycythemia due to EPO receptor mutationUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
15.
GRCh37:
Chr19:11487884
GRCh38:
Chr19:11377208
EPORPrimary familial polycythemia due to EPO receptor mutationUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
16.
GRCh37:
Chr19:11494938
GRCh38:
Chr19:11384262
EPORPrimary familial polycythemia due to EPO receptor mutationBenign
(Jan 13, 2018)
criteria provided, single submitter
17.
GRCh37:
Chr19:11494908
GRCh38:
Chr19:11384232
EPORPrimary familial polycythemia due to EPO receptor mutationUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
18.
GRCh37:
Chr19:11489381
GRCh38:
Chr19:11378705
EPORK301EPrimary familial polycythemia due to EPO receptor mutationUncertain significance
(Jan 15, 2018)
criteria provided, single submitter
19.
GRCh37:
Chr19:11488900
GRCh38:
Chr19:11378224
EPORPrimary familial polycythemia due to EPO receptor mutationUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
20.
GRCh37:
Chr19:11494892
GRCh38:
Chr19:11384216
EPORPrimary familial polycythemia due to EPO receptor mutationUncertain significance
(Jan 15, 2018)
criteria provided, single submitter
21.
GRCh37:
Chr19:11494871
GRCh38:
Chr19:11384195
EPORG5RPrimary familial polycythemia due to EPO receptor mutationUncertain significance
(Apr 27, 2017)
criteria provided, single submitter
22.
GRCh37:
Chr19:11493918
GRCh38:
Chr19:11383242
EPORPrimary familial polycythemia due to EPO receptor mutationUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
23.
GRCh37:
Chr19:11488731
GRCh38:
Chr19:11378055
EPORS486PPrimary familial polycythemia due to EPO receptor mutationLikely benign
(Jan 13, 2018)
criteria provided, single submitter
24.
GRCh37:
Chr19:11488720
GRCh38:
Chr19:11378044
EPORPrimary familial polycythemia due to EPO receptor mutationUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
25.
GRCh37:
Chr19:11492737
GRCh38:
Chr19:11382061
EPOR, LOC130063571A99Vnot provided, Primary familial polycythemia due to EPO receptor mutationBenign/Likely benign
(May 21, 2018)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr12:111885295
GRCh38:
Chr12:111447491
SH2B3E193K, E395KPrimary familial polycythemia due to EPO receptor mutation, Thrombocythemia 1Pathogenic
(Mar 16, 2018)
criteria provided, single submitter
27.
GRCh37:
Chr12:111885310
GRCh38:
Chr12:111447506
SH2B3E198K, E400KPrimary familial polycythemia due to EPO receptor mutation, Primary myelofibrosis, Thrombocythemia 1,
not provided
Uncertain significance
(Oct 31, 2018)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr19:11494951
GRCh38:
Chr19:11384275
EPORPrimary familial polycythemia due to EPO receptor mutationUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
29.
GRCh37:
Chr19:11494891
GRCh38:
Chr19:11384215
EPORPrimary familial polycythemia due to EPO receptor mutationUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
30.
GRCh37:
Chr19:11494860
GRCh38:
Chr19:11384184
EPORnot provided, Primary familial polycythemia due to EPO receptor mutationBenign/Likely benign
(May 20, 2022)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr19:11494762
GRCh38:
Chr19:11384086
EPORPrimary familial polycythemia due to EPO receptor mutationBenign
(Jan 13, 2018)
criteria provided, single submitter
32.
GRCh37:
Chr19:11493887
GRCh38:
Chr19:11383211
EPORG46Enot provided, Primary familial polycythemia due to EPO receptor mutationBenign
(Jan 1, 2023)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr19:11493856
GRCh38:
Chr19:11383180
EPORnot provided, Primary familial polycythemia due to EPO receptor mutationBenign
(Dec 31, 2019)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr19:11493809
GRCh38:
Chr19:11383133
EPORV72APrimary familial polycythemia due to EPO receptor mutationLikely benign
(Jan 12, 2018)
criteria provided, single submitter
35.
GRCh37:
Chr19:11492515
GRCh38:
Chr19:11381839
EPORnot provided, Primary familial polycythemia due to EPO receptor mutationBenign
(Dec 31, 2019)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr19:11492395
GRCh38:
Chr19:11381719
EPORnot provided, Primary familial polycythemia due to EPO receptor mutationBenign/Likely benign
(Sep 1, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr19:11492385
GRCh38:
Chr19:11381709
EPORA190SPrimary familial polycythemia due to EPO receptor mutationBenign
(Jan 13, 2018)
criteria provided, single submitter
38.
GRCh37:
Chr19:11491875
GRCh38:
Chr19:11381199
EPORL199PPrimary familial polycythemia due to EPO receptor mutationUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
39.
GRCh37:
Chr19:11491814
GRCh38:
Chr19:11381138
EPORnot provided, Primary familial polycythemia due to EPO receptor mutationBenign
(Dec 31, 2019)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr19:11489418
GRCh38:
Chr19:11378742
EPORPrimary familial polycythemia due to EPO receptor mutationUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
41.
GRCh37:
Chr19:11489207
GRCh38:
Chr19:11378531
EPORP327LPrimary familial polycythemia due to EPO receptor mutationUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
42.
GRCh37:
Chr19:11489165
GRCh38:
Chr19:11378489
EPORT341MPrimary familial polycythemia due to EPO receptor mutationLikely benign
(Jan 12, 2018)
criteria provided, single submitter
43.
GRCh37:
Chr19:11489146
GRCh38:
Chr19:11378470
EPORInborn genetic diseases, not provided, Primary familial polycythemia due to EPO receptor mutation
Benign/Likely benign
(Aug 4, 2023)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr19:11489049
GRCh38:
Chr19:11378373
EPORP380Anot provided, Primary familial polycythemia due to EPO receptor mutationBenign
(Jun 3, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr19:11489048
GRCh38:
Chr19:11378372
EPORP380LPrimary familial polycythemia due to EPO receptor mutationBenign
(Jan 13, 2018)
criteria provided, single submitter
46.
GRCh37:
Chr19:11488789
GRCh38:
Chr19:11378113
EPORnot provided, Primary familial polycythemia due to EPO receptor mutationBenign
(May 3, 2022)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr19:11488760
GRCh38:
Chr19:11378084
EPORA476VPrimary familial polycythemia due to EPO receptor mutationBenign
(Jan 13, 2018)
criteria provided, single submitter
48.
GRCh37:
Chr19:11488759
GRCh38:
Chr19:11378083
EPORPrimary familial polycythemia due to EPO receptor mutationLikely benign
(Jan 13, 2018)
criteria provided, single submitter
49.
GRCh37:
Chr19:11488743
GRCh38:
Chr19:11378067
EPORD482NPrimary familial polycythemia due to EPO receptor mutation, Inborn genetic diseasesLikely benign
(Oct 5, 2021)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr19:11488625
GRCh38:
Chr19:11377949
EPORPrimary familial polycythemia due to EPO receptor mutationBenign
(Jan 13, 2018)
criteria provided, single submitter
51.
GRCh37:
Chr19:11488235
GRCh38:
Chr19:11377559
EPORPrimary familial polycythemia due to EPO receptor mutationBenign
(Jan 13, 2018)
criteria provided, single submitter
52.
GRCh37:
Chr19:11488156
GRCh38:
Chr19:11377480
EPORPrimary familial polycythemia due to EPO receptor mutationBenign
(Jan 12, 2018)
criteria provided, single submitter
53.
GRCh37:
Chr19:11488083
GRCh38:
Chr19:11377407
EPORPrimary familial polycythemia due to EPO receptor mutationBenign
(Jan 13, 2018)
criteria provided, single submitter
54.
GRCh37:
Chr19:11488041
GRCh38:
Chr19:11377365
EPORPrimary familial polycythemia due to EPO receptor mutationUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
55.
GRCh37:
Chr19:11487990
GRCh38:
Chr19:11377314
EPORPrimary familial polycythemia due to EPO receptor mutationBenign
(Jan 12, 2018)
criteria provided, single submitter
56.
GRCh37:
Chr19:11487976
GRCh38:
Chr19:11377300
EPORPrimary familial polycythemia due to EPO receptor mutationBenign
(Jan 12, 2018)
criteria provided, single submitter
57.
GRCh37:
Chr19:11488871
GRCh38:
Chr19:11378195
EPORW439*Acute megakaryoblastic leukemia without down syndromeLikely pathogenic
(Sep 1, 2020)
criteria provided, single submitter
58.
GRCh37:
Chr19:11488725
GRCh38:
Chr19:11378049
EPORP488SPrimary familial polycythemia due to EPO receptor mutation, not provided, Intellectual disability-hypotonic facies syndrome, X-linked, 1
Benign/Likely benign
(Sep 27, 2022)
criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr19:11488877
GRCh38:
Chr19:11378201
EPORR437HPrimary familial polycythemia due to EPO receptor mutation, not providedBenign
(Mar 15, 2022)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr9:5044432
GRCh38:
Chr9:5044432
INSL6, JAK2G127DPrimary myelofibrosis, Thrombocythemia 3, Primary familial polycythemia due to EPO receptor mutation,
Acquired polycythemia vera, Budd-Chiari syndrome, Acute myeloid leukemia,
not provided
Benign/Likely benign
(Jul 27, 2022)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr9:5126343
GRCh38:
Chr9:5126343
INSL6, JAK2R1063H, R658H, R914HBudd-Chiari syndrome, Primary familial polycythemia due to EPO receptor mutation, Acquired polycythemia vera,
Acute myeloid leukemia, Primary myelofibrosis, Thrombocythemia 3,
not specified, not provided
Benign/Likely benign
(Oct 1, 2023)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr12:111856571
GRCh38:
Chr12:111418767
SH2B3E208*Primary familial polycythemia due to EPO receptor mutationAffects
(Sep 16, 2010)
no assertion criteria provided
63.
GRCh37:
Chr19:11488897-11488898
GRCh38:
Chr19:11378221-11378222
EPORS432fsPrimary familial polycythemia due to EPO receptor mutationAffects
(Oct 1, 1999)
no assertion criteria provided
64.
GRCh37:
Chr19:11488909
GRCh38:
Chr19:11378233
EPORY426*Primary familial polycythemia due to EPO receptor mutationAffects
(Jul 1, 1998)
no assertion criteria provided
65.
GRCh37:
Chr19:11488882-11488888
GRCh38:
Chr19:11378206-11378212
EPORQ434fsPrimary familial polycythemia due to EPO receptor mutationAffects
(Sep 1, 1997)
no assertion criteria provided
66.
GRCh37:
Chr19:11488727
GRCh38:
Chr19:11378051
EPORN487Snot specified, not provided, Primary familial polycythemia due to EPO receptor mutation
Benign/Likely benign
(Aug 15, 2023)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr19:11488905-11488906
GRCh38:
Chr19:11378229-11378230
EPORI428fsPrimary familial polycythemia due to EPO receptor mutationAffects
(Sep 1, 1997)
no assertion criteria provided
68.
GRCh37:
Chr19:11488898-11488899
GRCh38:
Chr19:11378222-11378223
EPORD430fsPrimary familial polycythemia due to EPO receptor mutationAffects
(Jul 1, 1995)
no assertion criteria provided
69.
GRCh37:
Chr19:11488870
GRCh38:
Chr19:11378194
EPORW439*Primary familial polycythemia due to EPO receptor mutationAffects
(Feb 1, 1998)
no assertion criteria provided
70.
GRCh37:
Chr9:5073770
GRCh38:
Chr9:5073770
INSL6, JAK2V617F, V212F, V468FPrimary familial polycythemia due to EPO receptor mutation, Acute myeloid leukemia, Primary myelofibrosis,
Thrombocythemia 3, Budd-Chiari syndrome, Acquired polycythemia vera,
Thrombocythemia 3, not provided, Acquired polycythemia vera,
Primary myelofibrosis
Pathogenic/Likely pathogenic
(Apr 27, 2023)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination